Scientists at Fred Hutchinson Cancer Research Center have transplanted brain cancer patients' own gene-modified blood stem cells in order to protect their bone marrow against chemotherapy’s toxic side effects. Initial results of the ongoing, small trial, involving three patients with glioblastoma, showed that two patients survived longer than predicted if they had not been given the transplants, and a third patient remains alive with no disease progression almost three years after...
Trending Articles
More Pages to Explore .....